Irinotecan and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases From Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Brain and Central Nervous System Tumors
Related studies linked through entity extraction aliases.
Imatinib Mesylate, Vatalanib, and Hydroxyurea in Treating Patients With Recurrent or Relapsed Malignant Glioma
- Status
- COMPLETED
- Phase
- PHASE1
Temozolomide + Everolimus in Newly Diagnosed, Recurrent, or Progressive Malignant Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- PHASE1
Stress Reduction Program in Patients With Malignant Brain Tumors and Their Family Caregivers
- Status
- COMPLETED
- Phase
- NA
Cisplatin and Temozolomide in Treating Young Patients With Malignant Glioma
- Status
- UNKNOWN
- Phase
- PHASE2
Erlotinib Alone or in Combination With Radiation Therapy in Treating Young Patients With Refractory or Relapsed Malignant Brain Tumors or Newly Diagnosed Brain Stem Glioma
- Status
- UNKNOWN
- Phase
- PHASE1
Capecitabine and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Nonmetastatic Brain Stem Glioma or High-Grade Glioma
- Status
- COMPLETED
- Phase
- PHASE1
Imatinib Mesylate and Temozolomide in Treating Patients With Malignant Glioma
- Status
- COMPLETED
- Phase
- PHASE1
Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) With Bevacizumab and Irinotecan for Malignant Glioma
- Status
- COMPLETED
- Phase
- PHASE2
Vinblastine and Carboplatin in Treating Young Patients With Newly Diagnosed or Recurrent Low-Grade Glioma
- Status
- COMPLETED
- Phase
- PHASE1
ATN-161 and Carboplatin in Treating Patients With Recurrent Malignant Glioma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Polyvinylpyrrolidone-Sodium Hyaluronate Gel in Reducing Pain From Oral Mucositis in Young Patients With Cancer
- Status
- UNKNOWN
- Phase
- NA
Vatalanib in Treating Patients With Recurrent or Progressive Meningioma
- Status
- COMPLETED
- Phase
- PHASE2
Developing Interview Questions to Estimate Workplace Exposure to Electric and Magnetic Fields
- Status
- COMPLETED
- Phase
- N/A
Bevacizumab in Treating Patients With Recurrent or Progressive Glioma
- Status
- COMPLETED
- Phase
- PHASE2
Cellular Adoptive Immunotherapy in Treating Patients With Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- PHASE2
Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Thiotepa and Radiation Therapy in Treating Young Patients With Newly Diagnosed Malignant Brain Tumors
- Status
- UNKNOWN
- Phase
- PHASE2
Radiation Therapy (RT) and Temozolomide (TMZ) in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma
- Status
- COMPLETED
- Phase
- PHASE3
Talabostat Combined With Temozolomide or Carboplatin in Treating Young Patients With Relapsed or Refractory Brain Tumors or Other Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1